Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy
Year: 2026
Type: article
Study design: Observational Study
Source: Blood Cancer Discovery
Authors: Jan H. Frenking, Christine Riedhammer, Thomas Hielscher, Christoph Schaefers, Lisa B. Leypoldt, Marie Harzer, David Sedloev, Valentine Landrin, Niklas Kehl, Mirco J. Friedrich, Xiang Zhou, Maximilian Steinhardt, Philipp Weis, Julia Mersi, Johannes Waldschmidt, Niels Weinhold, K. Martin Kortüm, Carsten Müller-Tidow, Hermann Einsele, Sandra Sauer, Katja Weisel, Tim Richardson, Raphael Teipel, Leo Rasche, Marc S. Raab
Institutions: German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, University of Würzburg, Universitätsklinikum Würzburg, University Medical Center Hamburg-Eppendorf, Broad Institute, Harvard University, National Center for Tumor Diseases, University Hospital Cologne, University Hospital Carl Gustav Carus
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G8856798436
OpenAlex ID: W7128803439
